noncontiguous stage II adult diffuse large cell lymphoma
Showing 9976 - 10000 of >10,000
Hepatocellular Carcinoma Trial (DEB-TACE, PVL/PVE+DEB-TACE)
Not yet recruiting
- Hepatocellular Carcinoma
- DEB-TACE
- PVL/PVE+DEB-TACE
- (no location specified)
Nov 1, 2021
Malaria Trial (BNT165e, Placebo)
Not yet recruiting
- Malaria
- BNT165e
- Placebo
- (no location specified)
Sep 29, 2023
ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)
Not yet recruiting
- ALL
- +3 more
- Transcranial photobiomodulation (tPBM) - Mobile System
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 6, 2022
Autism Spectrum Disorder Trial in Boston (Transcranial Photobiomodulation (tPBM), Placebo/ Sham)
Recruiting
- Autism Spectrum Disorder
- Transcranial Photobiomodulation (tPBM)
- Placebo/ Sham
-
Boston, MassachusettsMassachusetts General Hospital
May 2, 2022
Eye Diseases Trial in Guangzhou
Recruiting
- Eye Diseases
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
May 4, 2022
Symptomatic Neuroma, Amputation, Chronic Nerve Pain Trial in Boston, Lubbock (Axoguard Nerve CapĀ®)
Recruiting
- Symptomatic Neuroma
- +2 more
- Axoguard Nerve CapĀ®
-
Boston, Massachusetts
- +1 more
Apr 21, 2022
Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)
Not yet recruiting
- Carcinoma, Renal Cell
- Autologous alpha-DC1/TBVA vaccine
- Cabozantinib
-
Pittsburgh, PennsylvaniaUPMC Department of Urology
Jan 5, 2023
Stage IV Periodontitis, Orthodontic Tooth Movement Trial in Madrid (Micro-ostoperforations (MOPs))
Recruiting
- Stage IV Periodontitis
- Orthodontic Tooth Movement
- Micro-ostoperforations (MOPs)
-
Madrid, SpainFaculty of Odontology, University Complutense Madrid
Sep 28, 2023
Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United Kingdom, United States (Camidanlumab tesirine)
Completed
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Camidanlumab tesirine
-
Duarte, California
- +11 more
Jul 12, 2021
ADHD Trial (PROBECO, Formulation-based cognitive behavioral therapy)
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- PROBECO
- Formulation-based cognitive behavioral therapy
- (no location specified)
Oct 6, 2023
Ovarian Cancer Trial in Seoul (Cellgram-DC)
Terminated
- Ovarian Cancer
- Cellgram-DC
-
Seoul, Korea, Republic ofAsan medical center
Dec 29, 2022
Atrial Fibrillation Trial (Clinical monitoring using the Ti.Care app (https://ti.care/es), Usual care)
Not yet recruiting
- Atrial Fibrillation
- Clinical monitoring using the Ti.Care app (https://ti.care/es)
- Usual care
- (no location specified)
May 30, 2023
Pertussis Immunisation, Diphtheria Immunisation, Tetanus Immunisation Trial in Cape Town (Tetanus Toxoid, Reduced Diphtheria
Recruiting
- Pertussis Immunisation
- +3 more
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
-
Cape Town, South Africa
- +2 more
Dec 2, 2022
Testicular Cancer Trial in Groningen (Androgel (Testosterone gel), Placebo gel)
Recruiting
- Testicular Cancer
- Androgel (Testosterone gel)
- Placebo gel
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 12, 2022
Breast Cancer Trial in Lutherville-Timonium (CS-1000 labeled SVF cells)
Withdrawn
- Breast Cancer
- CS-1000 labeled SVF cells
-
Lutherville-Timonium, MarylandCosmeticSurg
Jun 21, 2022
Hematological Tumors Trial in Beijing (TQB2825 injection)
Recruiting
- Hematological Tumors
- TQB2825 injection
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Aug 4, 2022
Significant Carotid Stenosis on Retinal Perfusion Measured Via
Recruiting
- Stroke, Ischemic
- Stenosis, Carotid
- Automated retinal oximetry
-
Olomouc, CzechiaUniversity Hospital Olomouc
Oct 18, 2023
Healthy Volunteers Trial in Shanghai (TAK-279, Placebo)
Not yet recruiting
- Healthy Volunteers
- TAK-279
- Placebo
-
Shanghai, ChinaHuashan Hospital Fudan University
Oct 27, 2023
Mass Balance Recovery Trial in Baltimore ([14C]-D-0502)
Active, not recruiting
- Mass Balance Recovery
-
Baltimore, MarylandSite Location
May 19, 2022
Diabetic Peripheral Neuropathy Trial in Worldwide (LY3556050, Placebo)
Not yet recruiting
- Diabetic Peripheral Neuropathy
- LY3556050
- Placebo
-
Mesa, Arizona
- +54 more
Oct 3, 2023
Surgery, Cardiac, Tranxemic Acid, Activated Clotting Time Trial (Tranexamic acid)
Not yet recruiting
- Surgery, Cardiac
- +4 more
- Tranexamic acid
- (no location specified)
Oct 30, 2023
Obesity Trial in San Antonio (Fit for Duty-mobile, m-Health Control)
Not yet recruiting
- Obesity
- Fit for Duty-mobile
- m-Health Control
-
San Antonio, TexasJoint Base San Antonio-Lackland
Oct 25, 2023
Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
Active, not recruiting
- Lung Cancer
- Retrospective Study
-
Dallas, TexasUT Southwestern Medical Center
May 4, 2022
Class II Malocclusion Trial in Mansoura (twin block, twin block combined with low level laser)
Recruiting
- Class II Malocclusion
- twin block
- twin block combined with low level laser
-
Mansoura, Dakahleya, EgyptFaculty of Dentistry
Sep 5, 2023